# Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer

> **NCT00859027** · PHASE4 · COMPLETED · sponsor: **UConn Health** · enrollment: 50 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** risedronate
- **DRUG:** Placebo risedronate oral tablet

## Key facts

- **NCT ID:** NCT00859027
- **Lead sponsor:** UConn Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2008-03
- **Final completion:** 2009-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00859027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00859027, "Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00859027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*